NAVARINI, LUCA
 Distribuzione geografica
Continente #
EU - Europa 29
SA - Sud America 2
AF - Africa 1
NA - Nord America 1
Totale 33
Nazione #
IT - Italia 16
RU - Federazione Russa 9
CO - Colombia 2
CZ - Repubblica Ceca 2
DE - Germania 1
SE - Svezia 1
TN - Tunisia 1
US - Stati Uniti d'America 1
Totale 33
Città #
Rome 13
Bogotá 2
Krasnodar 2
Moscow 2
Sciacca 2
Sochi 2
Volgograd 2
Council Bluffs 1
Douane 1
Frankfurt am Main 1
Padova 1
St Petersburg 1
Stockholm 1
Totale 31
Nome #
Personal attitudes and denialist views about the COVID-19 pandemic in Italy: a national survey, file 5b46ddb2-6f4b-41ea-898f-10adc62dd065 26
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles, file 46cb5c2a-03fa-4b9b-93e3-fa3e64112cfe 2
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis, file ac77662d-77b7-4128-b876-7b1e908d4fb1 2
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units, file de024af2-0d6c-70dc-e053-6605fe0a0424 2
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management., file de024af2-13e9-70dc-e053-6605fe0a0424 1
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues., file de024af2-7a99-70dc-e053-6605fe0a0424 1
Totale 34
Categoria #
all - tutte 88
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221 0 0 0 0 0 0 0 1 0 0 0 0
2022/202330 0 0 1 4 2 0 4 11 2 0 0 6
2023/20243 0 0 2 0 0 0 1 0 0 0 0 0
Totale 34